Article
Clinical relevance of partial HPV genotyping in cervical cancer screening.
Scientific reports - 4 Feb 2026
Leino Aarno, Numminen Eero, Kares Saara, Meriö Markus, Kotaniemi-Talonen Laura, Kholová Ivana, Louvanto Karolina
Abstract excerpt
Partial human papillomavirus (HPV) genotyping is increasingly used to triage high-risk (HR)-HPV-positive women in national cervical cancer screening. This study evaluated whether separate triage for HPV genotypes 16 and 18 could enhance the effectiveness of Finland's program. Data from 76,482 women participating in primary HPV screening in Tampere and surrounding municipalities (2012-2023) were analyzed. Partial...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
